Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ceftolozane/tazobactam

Development of resistance to ceftolozane/tazobactam therapy: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Cabrera N, et al. Clinical and microbiological outcomes associated with real-world use of ceftolozane/tazobactam. Open Forum Infectious Diseases 6 (Suppl. 2): S768-S769 (plus poster) abstr. 2248, Oct 2019. Available from: URL: https://doi.org/10.1093/ofid/ofz360.1926 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ceftolozane/tazobactam. Reactions Weekly 1791, 63 (2020). https://doi.org/10.1007/s40278-020-74908-8

    Download citation